NGS data analysis for microorganism identification

Perform simpler and faster analysis for both infectious and non-infectious microorganisms through a efficient and customized bioinformatics pipelines.

Play Video

Meet Varsmetagen
Platform for analysis and identification of microorganisms.

Discover our portfolio


Diagnosis of virus RNA
with high sensitivity


Targeted detection of
bacteria and fungi

Metagenomic NGS

Pathogen detection with
high specificity and more

Make a Varsmetagen demo

Step by step

1.Routine configuration

Register an analysis routine specifying basic data, such as the desired bioinformatics pipeline, sequencing platform and kit used in the process.

2.File upload

In the upload step, upload the NGS sequencing raw files of the clinical samples. Varmetagen accepts the main formats (FASTQ, FASTQ.GZ and BAM).

3.Data processing

It is possible to relate each sample (input files) to information such as collection date, sample type, unique ID, previously registered patient. Then, just start the processing and track its progress.

4. Analysis and support for results

After the processing is done, it’s possible to evaluate quality metrics and the diversity of microorganisms present in each sample individually. Thus, ensuring more security and practicality in the analysis (interpretation of results for generating reports).

Advantages of using Varsmetagen®

Analysis time optimization

Significantly reduce and optimize the time for processing, sorting variants and generating reports from NGS human data.

End-to-end automated processing

Quality parameter evaluation, mapping, multi-variant callers, database annotation, and automatic pre-sorting following ACMG, AMP, PALC, and CAP guidelines.

Clinical interpretation support

Varstation grants you easy access to more than 200 genetic variant databases. Those include data for germline and somatic analysis.

Data filtering

Data filtering mechanism that incorporates all annotated mutation data - including human phenotypes, patient clinical history and associated diseases (OMIM/UniProt).

We are part of the best Hospital in Latin America:

We preserve the diversity, quality and organizational culture of Hospital Israelita Albert Einstein, considered by the América Economía Intelligence’s ranking as the best hospital in Latin America.

Precision medicine for
infectious disease diagnosis

Sucess Case

The SarsOmics project, funded by CNPq, emerged at the beginning of the pandemic and performs the sequencing of the COVID-19 virus, SARS-CoV-2, in addition to studying co-infections with other viruses, bacteria and fungi in the respiratory tract of patients with COVID-19.

A huge amount of NGS data has been generated by the project, and the practicality and scalability of Varsmetagen has helped in the process of analysis and interpretation of these results.

Sucess Case

During the COVID-19 pandemic, Varsomics, in partnership with Albert Einstein Israelite Hospital, developed the world’s first test for the diagnosis of the new coronavirus based on Next Generation Sequencing (NGS). The test, which was known as VarsVid, identifies the presence of the virus, functioning as a diagnostic tool to be used from the first day of infection, in the same way as RT-PCR, which makes it an alternative for adopting a diagnostic test. Processing takes up to 72 hours, and has 95% sensitivity and 99% specificity, or positive, there are no cases of false.